Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro
- 23 Downloads
Phosphonoformate, ganciclovir, zidovudine and the novel acyclic nucleotide analogues (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA] and (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] were evaluated for their inhibitory effect on colony forming unit formation by human granulocyte-macrophage progenitor cells (obtained from 11 healthy volunteers) in vitro. The 50 % inhibitory dose of zidovudine, (S)-HPMPA, (S)-HPMPC, ganciclovir and phosphonoformate were 10.61, 16.55, 80.88, 41.02 and 668.64 µM, respectively, when the median-effect principle was applied. The bone marrow toxicity of zidovudine used at a low concentration (3.74 µM) was significantly decreased if the drug was combined with (S)-HPMPA, (S)-HPMPC or ganciclovir. If used at higher concentrations (74.90 µM), zidovudine showed increased myelotoxicity in the presence of (S)-HPMPA and ganciclovir, but not (S)-HPMPC.
KeywordsNucleotide Bone Marrow Human Immunodeficiency Virus Healthy Volunteer Adenine
Unable to display preview. Download preview PDF.
- 1.Mitsuya H, Weinhold KJ, Furman PA, St. Clair MH, Nusinoff-Lehrman S, Gallo RC, Bolognesi D, Barry DW, Broder S: 3′-azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proceedings of the National Academy of Sciences of the USA 1985, 82: 7096–7100.PubMedGoogle Scholar
- 2.Matthews T, Boehme R: Antiviral activity and mechanism of action of ganciclovir. Reviews of Infectious Diseases 1988, 10, Supplement 3: 490–494.Google Scholar
- 6.Buhles WC, Mastre BJ, Tinker AJ, Strand V, Koretz SH, the Syntex Collaborative Ganciclovir Treatment Group: Ganciclovir treatment of life-or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Reviews of Infectious Diseases 1988, 10, Supplement, 3: 495–506.Google Scholar
- 7.Winston DJ, Ho WG, Bartoni K, Holland GN, Mitsuya RT, Gale RP, Busuttil RW, Champlin RE: Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients. Reviews of Infectious Diseases 1988, 10, Supplement 3: 547–553.Google Scholar
- 16.Bhalla K, Birkhofer M, Grant S, Graham G: The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3′-azido-3′-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Experimental Hematology 1989, 17: 17–20.PubMedGoogle Scholar